Pomerantz LLP is investigating Astrana Health and its executives for potential securities fraud following a short-seller report by Glass House Research. The report accused Astrana of relying on aggressive acquisitions and questionable management estimates instead of organic growth, and raised concerns about a $545 million related-party loan and Medicare regulatory risks in 2027. After the report's release on September 17, 2026, Astrana's stock price fell by over 9%. The investigation could lead to legal action and impact investor confidence in the company.
The story concerns Astrana Health, Inc. For readers following the health sector, here is Pluang's market snapshot as of Sep 25, 2026 03:02 WIB: Of 100 priced health-sector US stocks tradable on Pluang, 33 rose and 67 fell today. Notable movers include CRSP at USD 55.93 with a -5.25% change, RXRX at USD 3.88 with a +4.86% change, and INO at USD 1.30 with a +4.84% change.
Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...
Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home compl...
Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...
REGENXBIO announced positive 3-year results from its Phase II ALTITUDE trial of surabgene lomparvovec (sura-vec) for non-proliferative diabetic retinopathy (NPDR). A single in-office gene therapy dose led to over 60% of participants achieving more th...
Ethereum (ETH) has printed its first higher high since its August 2025 peak, breaking a year-long pattern of lower highs. It surpassed the $2,438 resistance level, which has now turned into support, signaling a more bullish weekly structure. However,...
